In parallel, BKM120, a pan-class I PI3K inhibitor, was tested in combination with mFOLFOX6 (5-FU/leucovorin plus oxaliplatin) in metastatic PCa patients (NCT01571024). This evidence concerns the gene PIK3CA and posterior cortical atrophy.